Skip to main navigation Skip to main content

CMH : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

2
results for

"Jiaorong Qu"

Article category

Keywords

Publication year

"Jiaorong Qu"

Correspondence

Liver fibrosis, cirrhosis, and portal hypertension

  • 5,810 View
  • 63 Download
Review

Liver fibrosis, cirrhosis, and portal hypertension

Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis
Jiaorong Qu, Le Wang, Yufei Li, Xiaojiaoyang Li
Clin Mol Hepatol 2024;30(3):303-325.
Published online February 28, 2024
DOI: https://doi.org/10.3350/cmh.2024.0022
Liver sinusoidal endothelial cells (LSECs) are liver-specific endothelial cells with the highest permeability than other mammalian endothelial cells, characterized by the presence of fenestrae on their surface, the absence of diaphragms and the lack of basement membrane. Located at the interface between blood and other liver cell types, LSECs mediate the exchange of substances between the blood and the Disse space, playing a crucial role in maintaining substance circulation and homeostasis of multicellular communication. As the initial responders to chronic liver injury, the abnormal LSEC activation not only changes their own physicochemical properties but also interrupts their communication with hepatic stellate cells and hepatocytes, which collectively aggravates the process of liver fibrosis. In this review, we have comprehensively updated the various pathways by which LSECs were involved in the initiation and aggravation of liver fibrosis, including but not limited to cellular phenotypic change, the induction of capillarization, decreased permeability and regulation of intercellular communications. Additionally, the intervention effects and latest regulatory mechanisms of anti-fibrotic drugs involved in each aspect have been summarized and discussed systematically. As we studied deeper into unraveling the intricate role of LSECs in the pathophysiology of liver fibrosis, we unveil a promising horizon that pave the way for enhanced patient outcomes.

Citations

Citations to this article as recorded by  Crossref logo
  • Dark tea ameliorates liver fibrosis via FXR/TGR5-mediated intestinal permeability and liver sinusoidal capillarization
    Chen-Yu Wang, Sen Liu, Chong Gao, Xu Dai, Li-Hua Lian, Zhen-Yu Cui, Ji-Xing Nan, Yan-Ling Wu
    Journal of Ethnopharmacology.2026; 354: 120537.     CrossRef
  • Targeting LOXL1-expressing Hepatic Stellate Cell Inhibits Fibrogenesis and Sinusoid Angiogenesis via LOXL1/RUNX1/VEGFA Axis During Progression of Liver Fibrosis
    Xuzhen Yan, Qi Han, Yiwen Wang, Weiyu Li, Ning Zhang, Xu Fan, Wei Chen, Hong You, Aiting Yang
    Cellular and Molecular Gastroenterology and Hepatology.2026; 20(2): 101637.     CrossRef
  • Spatial patterning strategies for liver tissue engineering: Biofabrication technologies and applications
    Haram Nah, Ashlin R. Michell, Kerry M. Rogy, Owen J. Lally, Salman R. Khetani
    Advanced Drug Delivery Reviews.2026; 228: 115737.     CrossRef
  • Precision Targeting of Hepatic Stellate Cells: Nanotherapeutic Strategies for Liver Fibrosis Regression
    Xinying Ma, Dawei Chen, Ming Zhao, Haiyang Hu
    WIREs Nanomedicine and Nanobiotechnology.2026;[Epub]     CrossRef
  • Recent advances of nanomaterials in imaging liver fibrosis
    Jin Cui, Shuxuan Zhang, Xueli Xu, Ke Ren, Mengzhen Dong, Zhaokun Nie, Yang Xu, Xiaohui Dai, Peng Xu, Shuo Sun, Xinya Zhao, Xiao Sun
    BMEMat.2025;[Epub]     CrossRef
  • Immune Checkpoints and the Immunology of Liver Fibrosis
    Ioannis Tsomidis, Argyro Voumvouraki, Elias Kouroumalis
    Livers.2025; 5(1): 5.     CrossRef
  • Advances in intrahepatic and extrahepatic vascular dysregulations in cirrhotic portal hypertension
    Yanqiu Li, Bingbing Zhu, Ke Shi, Yu Lu, Xuanwei Zeng, Yongqi Li, Qun Zhang, Ying Feng, Xianbo Wang
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics
    Xiao Ma, Tengda Huang, Xiangzheng Chen, Qian Li, Mingheng Liao, Li Fu, Jiwei Huang, Kefei Yuan, Zhen Wang, Yong Zeng
    Signal Transduction and Targeted Therapy.2025;[Epub]     CrossRef
  • Injury and Fibrosis at the Myoaponeurotic Junction of Pectoralis Major and Supracoracoideus Muscles in Broiler Chickens
    Takeshi Kawasaki, Tomohito Iwasaki, Takafumi Watanabe, Michi Yamada, Naoyuki Maeda, Yasuhiro Hasegawa, Naoki Takahashi, Ryosuke Kobayashi
    The Journal of Poultry Science.2025; 62: n/a.     CrossRef
  • Sulfur dioxide-releasing nanomotors improve the therapeutic effect of liver fibrosis by restoring the fenestrae of sinusoids
    Lin Chen, Zhengwei Chen, Di Shi, Haifeng Ke, Chun Mao, Mimi Wan
    Journal of Colloid and Interface Science.2025; 692: 137557.     CrossRef
  • Reconstructing the hepatocellular carcinoma microenvironment: the current status and challenges of 3D culture technology
    Ting Xiong, Kai Wang
    Discover Oncology.2025;[Epub]     CrossRef
  • Liver Sinusoidal Endothelial Cells in the Regulation of Immune Responses and Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease
    Munish Puri, Snehal Sonawane
    International Journal of Molecular Sciences.2025; 26(9): 3988.     CrossRef
  • Chronic Inflammation and Immune Dysregulation in Metabolic-Dysfunction-Associated Steatotic Liver Disease Progression: From Steatosis to Hepatocellular Carcinoma
    Young-Min Jee, Jeong-Yoon Lee, Tom Ryu
    Biomedicines.2025; 13(5): 1260.     CrossRef
  • Mechanism-guided drug development and treatment for liver fibrosis: a clinical perspective
    Xiangchang Zeng, Deliang Huang, Zhibin Zhu, Qingxian Cai, Yang Yang, Hongzhou Lu, Jun Chen
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Targeting endoplasmic reticulum proteostasis in liver fibrosis: From signaling mechanisms to therapeutic opportunities
    Yawei Kong, Zhengyang Chen, Zhentian Nie, Wei Chen
    Pharmacological Research.2025; 217: 107823.     CrossRef
  • Reactive oxygen species-responsive micelles targeting activated hepatic stellate cells for treating liver fibrosis
    Xin Yu Liu, He Ying Mao, Jun Sheng Hu, Tong Rui Dou, Ben Chi Liu, Chang Xiu Lin, Cheng-Hua Jin, Ming Guan Piao
    Journal of Controlled Release.2025; 385: 113997.     CrossRef
  • Liver Sinusoidal Endothelial Cells and Their Regulation of Immunology, Collagenization, and Bioreactivity in Fatty Liver: A Narrative Review
    Reem J. Abdulmajeed, Consolato M. Sergi
    International Journal of Molecular Sciences.2025; 26(16): 8006.     CrossRef
  • From cooperation to collapse: systemic failure in liver disease through a sociological lens
    Junyu Wang, Jingting Lei, Martin C. Harmsen, Han Moshage
    Exploration of Digestive Diseases.2025;[Epub]     CrossRef
  • Anogeissus leiocarpus (DC.) Guill. & Perr. extract-protected rats against CCl4-induced liver fibrosis
    Omokolade O. Alejolowo, Olarewaju M. Oluba, Oluyomi S. Adeyemi
    Journal of Taibah University Medical Sciences.2025; 20(4): 474.     CrossRef
  • Anti-hepatic fibrosis activity and mechanisms of natural polysaccharides: A comprehensive review
    Xing Yang, Mingyi Shao, Ruixia Zhao, Rui Li, Bingzhao Du, Qian Bi, Yanan Liu, Hongyan Cui
    International Journal of Biological Macromolecules.2025; 328: 147678.     CrossRef
  • 4EBP1 phosphorylation mediates TGF-β1-induced hepatic fibrosis and upregulates HIF-1α expression
    Yue Shi, Zhandong Lin, Congyue Zhang, Jiawei Cui, Yaoyao Mao, Mengjiao Sun, Dandan Zhao, Yuemin Nan, Dianxing Sun
    iScience.2025; 28(9): 113412.     CrossRef
  • YAP contributes to liver injury through mediating capillarization of liver sinusoidal endothelial cells via GATA6/eNOS signaling
    Junjun Wang, Zhenyang Shen, Guangwen Chen, Weiming Dai, Zhu Mei, Bo Shen, Yuecheng Guo, Jianxiang Wang, Hanjing Zhangdi, Qingqing Zhang, Jiaqi Gao, Qichao Ge, Hui Zhou, Hui Dong, Lungen Lu, Xiaobo Cai
    Cellular & Molecular Biology Letters.2025;[Epub]     CrossRef
  • Genomic medicine in hepatology: mechanisms and liver treatment strategies
    D. S. Kozlov, S. Rodimova, P. Filatov, A. Mozherov, P. S. Timashev, M. V. Zyuzin, D. S. Kuznetsova
    Molecular Medicine.2025;[Epub]     CrossRef
  • Piezo-mediated mechanically activated currents in organ fibrosis: Novel mechanisms and therapeutic strategies
    Ling Dong, Li-Chan Lin, Sui Mao, Zhen-Yu Liu, Peng Liu, Rui Li, Hui Tao, Ye Zhang
    Life Sciences.2025; 382: 124050.     CrossRef
  • Retinal Sensitivity Loss and Beyond in KCNV2-Related Retinopathy: The First Genetically Confirmed Case in Türkiye
    Özlem Ural Fatihoğlu, Ayşe Bozkurt Oflaz, Özlem Özkan, Hande Taylan Şekeroğlu, Ali Osman Saatçi
    Turkish Journal of Ophthalmology.2025; 55(6): 352.     CrossRef
  • Transcriptome Analyses of Liver Sinusoidal Endothelial Cells Reveal a Consistent List of Candidate Genes Associated with Endothelial Dysfunction and the Fibrosis Progression
    Penghui Li, Wenjie Xie, Hongjin Wei, Fan Yang, Yan Chen, Yinxiong Li
    Current Issues in Molecular Biology.2024; 46(8): 7997.     CrossRef
  • Correspondence to editorial on “Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis”
    Jiaorong Qu, Le Wang, Xiaojiaoyang Li
    Clinical and Molecular Hepatology.2024; 30(4): 1002.     CrossRef
  • Unlocking the role of liver sinusoidal endothelial cells: Key players in liver fibrosis: Editorial on “Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis”
    Yasuko Iwakiri
    Clinical and Molecular Hepatology.2024; 30(4): 673.     CrossRef
  • Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease
    Hui Gao, Yanchao Jiang, Ge Zeng, Nazmul Huda, Themis Thoudam, Zhihong Yang, Suthat Liangpunsakul, Jing Ma
    eGastroenterology.2024; 2(4): e100104.     CrossRef
  • Exploring the Role of Peroxisome Proliferator-Activated Receptors and Endothelial Dysfunction in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Ana Paula Madariaga Traconis, Misael Uribe-Esquivel, Varenka Julieta Barbero Becerra
    Cells.2024; 13(24): 2055.     CrossRef
  • Si-Wu-Tang improves liver fibrosis by restoring liver sinusoidal endothelial cell functionality and reducing communication with hepatic stellate cells
    Le Wang, Jiaorong Qu, Jianan Li, Xiaoyong Xue, Lingling Qin, Yufei Li, Yuanfeng Dou, Xiaohong Mu, Xiaojiaoyang Li
    Chinese Medicine.2024;[Epub]     CrossRef
  • 14,142 View
  • 428 Download
  • 29 Web of Science
  • Crossref